Medicared For All Logo

Daniel Mirda in Napa, California

Home California Napa

Daniel Mirda has Medical Oncology as his primary medical specialty. Their primary office is: 1100 Trancas St in Napa, California.

They're a part of the: Providence Medical Foundation medical group which has around 1,270 members. You can call their office at 707-253-7161 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Stanford University School Of Medicine and graduated in 1984 (around 40 years of experience). They are listed as doing telehealth appointments.


Daniel P Mirda Office Phone and Directions

Daniel Mirda
Providence Medical Foundation
1100 Trancas St
Napa, California 94558
707-253-7161


Patient Ratings
Please rate your experience with Daniel Mirda below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 707-253-7161


Enter a starting address:


Healthcare Info for Daniel Mirda

Medical School: Stanford University School Of Medicine
Graduation Year: 1984
The Primary Medical Specialty for Daniel Mirda is listed as: Medical Oncology
Approximate Years of Experience: 40
PAC (PECOS ID)#: 5991875908
NPI #: 1811963317
NPI Created On: 02/24/2006
NPI Last Updated Listed as: 11/08/2021
Primary Taxonomy Code: 207RH0000X
License Number:
G57247
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.


Services and Procedures include:

  1. Bone marrow biopsy and aspiration
  2. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  3. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
  4. New patient office or other outpatient visit, typically 60 minutes
  5. Established patient office or other outpatient visit, typically 15 minutes
  6. Established patient office or other outpatient, visit typically 25 minutes
  7. Established patient office or other outpatient, visit typically 40 minutes
  8. Initial hospital inpatient care, typically 70 minutes per day
  9. Subsequent hospital inpatient care, typically 15 minutes per day
  10. Subsequent hospital inpatient care, typically 25 minutes per day
  11. Subsequent hospital inpatient care, typically 35 minutes per day
  12. Physician telephone patient service, 11-20 minutes of medical discussion
  13. Physician telephone patient service, 21-30 minutes of medical discussion
  14. Telephone or internet assessment and management service provided by consultative physician with verbal and written report, 21-30 minutes of medical consultative discussion and review
  15. Telephone or internet assessment and management service provided by consultative physician, 31 minutes or more of medical consultative discussion and review
  16. Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic
  17. Injection, darbepoetin alfa, 1 microgram (non-esrd use)
  18. Injection, denosumab, 1 mg
  19. Injection, tbo-filgrastim, 1 microgram
  20. Leuprolide acetate (for depot suspension), 7.5 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788711481

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $106

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: FOOD & BEVERAGE EXPENSES FOR A MEETING WHICH MAY HAVE INCLUDED MULTIPLE DAYS AND MAY HAVE HAD MULTIPLE MEALS PER DAY

Record ID:: 818903755

Being Disputed:: No

Product Related: No


Payments Total: $7

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818903757

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54


Payments Total: $4

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819040239

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54


Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819040973

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54


Payments Total: $120

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: FOOD & BEVERAGE EXPENSES FOR A MEETING WHICH MAY HAVE INCLUDED MULTIPLE DAYS AND MAY HAVE HAD MULTIPLE MEALS PER DAY

Record ID:: 819047753

Being Disputed:: No

Product Related: No


Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819054497

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54


Payments Total: $130

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832151549

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ADCETRIS

Open Associated Drug #1: 51144-050-01


Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792813625

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $30

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783715011

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: EMPLICITI

Open Associated Drug #1: 0003-2291-11


Medical Oncology Professionals in Napa

1000 Trancas St
Napa, CA
Providence Medical Foundation

Providers in Providence Medical Foundation

1.Lea Dominique Abadies

1950 Sunny Crest Dr
Fullerton Ca 92835-3641
Providence Medical Foundation
Physician Assistant

2.Sonja Abbassi

27799 Medical Ctr Rd
Mission Viejo Ca 92691-6400
Providence Medical Foundation
Internal Medicine

3.Sonja Abbassi

1950 Sunny Crest Dr
Fullerton Ca 92835-3641
Providence Medical Foundation
Internal Medicine

4.Shenoda Abd Elmaseh

27799 Medical Ctr Rd
Mission Viejo Ca 92691-6400
Providence Medical Foundation
Family Practice

5.Shenoda Abd Elmaseh

1950 Sunny Crest Dr
Fullerton Ca 92835-3641
Providence Medical Foundation
Family Practice

6.Abdul Abdali

2700 Dolbeer St
Eureka Ca 95501-4736
Providence Medical Foundation
Hospitalist

View all 1,270 members of Providence Medical Foundation medical group